Digestion of Gluten in the Presence of Enzymes
GlutDigest
GlutDigest - Enzymes-assisted Gluten Digestion
1 other identifier
interventional
11
1 country
1
Brief Summary
This study evaluates the impact of two dietary supplements (Elevase® and DE111®) and of oatmeal properties on the digestion of gluten and starch and on the glycemic response.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2020
CompletedFirst Posted
Study publicly available on registry
July 28, 2020
CompletedStudy Start
First participant enrolled
October 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 8, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 8, 2021
CompletedApril 10, 2025
May 1, 2024
6 months
July 22, 2020
April 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Undigested wheat protein
Difference between the mean concentration of undigested wheat protein in ileal effluent samples.
9-hour period after the test meal
Secondary Outcomes (4)
Vegetative DE111 cells
9-hour period after the test meal
Glycemic response
At baseline, and at different time-points during 9 hours after after consuming the test meal.
Undigested starch
At baseline and once every hour in the 9-hour period after consumption of the test meal.
Undigested food particles
9-hour period after the test meal
Study Arms (4)
Meal A + Placebo
PLACEBO COMPARATOR350 mg Placebo capsule, taken by mouth, once, with Meal A
Meal A + Elevase®
EXPERIMENTAL350 mg Elevase® capsule, taken by mouth, once, with Meal A
Meal A + DE111®
EXPERIMENTAL350 mg DE111® capsule, taken by mouth, once, with Meal A
Meal B + Placebo
EXPERIMENTAL350 mg Placebo capsule, taken by mouth, once, with Meal B
Interventions
Maltodextrin capsule manufactured to mimic the Elevase® and DE111® capsules
Oatmeal porridge - serving of cooked oats containing 50g of carbohydrates (excluding sugars); Wheat cereal - serving of wheat cereal providing 1g of gluten; Water - 125 mL
Refrigerated oatmeal - serving of refrigerated oats containing 50g of carbohydrates (excluding sugars); Wheat cereal - serving of wheat cereal providing 1g of gluten; Water - 125 mL
Eligibility Criteria
You may qualify if:
- Subject has given written informed consent
- Subject has an ileostomy stable for at least 3 months post-operative and shows normal stoma functions
- Subject is otherwise healthy
- Subject is available to participate in the study sessions on the proposed dates
You may not qualify if:
- Subject has coeliac disease or allergy to wheat products and/or any other ingredients in the test meal and standard meals
- Case of obstruction of the stoma in the past 3 months
- Body mass index \< 18 kg/m2 or \> 30 kg/m2.
- Diagnosed mouth, throat or active gastrointestinal pathology (other than ileostomy) that may affect normal ingestion and digestion of food.
- History of pancreatic disease
- Subject is immunocompromised (HIV positive, transplant patient, on antirejection medications, on a steroid for \>30 days, or chemotherapy or radiotherapy within the last year)
- Subject has Type 1 or Type 2 diabetes mellitus.
- Subject has a history of bariatric surgery.
- Subject has a history of drug and/or alcohol abuse at the time of enrolment
- Subject is currently participating in another study, or plans to participate in another study during the study period
- Women of child-bearing potential who do not use an acceptable method of contraception
- Pregnant or nursing (lactating) women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Archer-Daniels-Midland Companylead
- Teagasccollaborator
- Atlantia Food Clinical Trialscollaborator
Study Sites (1)
Atlantia Food Clinical Trials
Cork, Cork, Ireland
Related Publications (1)
Smith F, Pan X, Bellido V, Toole GA, Gates FK, Wickham MS, Shewry PR, Bakalis S, Padfield P, Mills EN. Digestibility of gluten proteins is reduced by baking and enhanced by starch digestion. Mol Nutr Food Res. 2015 Oct;59(10):2034-43. doi: 10.1002/mnfr.201500262. Epub 2015 Aug 21.
PMID: 26202208BACKGROUND
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 22, 2020
First Posted
July 28, 2020
Study Start
October 19, 2020
Primary Completion
April 8, 2021
Study Completion
April 8, 2021
Last Updated
April 10, 2025
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share